Treeline Biosciences
PrivateLast Round
Series A
Extension
9/3/2025
Total Funding Raised
$1.1B
Company Overview
Treeline Biosciences is a biotechnology company focused on developing transformative precision medicines aimed at treating cancer and other serious conditions through a comprehensive drug discovery platform that integrates mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treeline Biosciences Comps
Public and private peers based on sector, stage, and business model.
Treeline Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | 9/3/2025 | ||||
| Early Funding | 10/17/2024 | ||||
| Early Funding | 10/11/2022 | ||||
| Series A | 4/30/2021 |
Key People
Founding team and executive leadership
Treeline Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Soleus Capital | Series A |
| Access Industries | Series A, Early Funding |
| Boxer Capital | Series A |
| GV | Series A Extension, Early Funding, Series A |
| Ajax Health | Series A Extension |
| ARCH Venture Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Portfolio advanced to human trials, indicating clinical stage.
- Sep 3, 2025
$200M raised in Series A Extension round.
Treeline Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Treeline Biosciences's valuation, stock price, and market status.
